"We are truly in a new era. We have opened the door to understanding and manipulating the biology of Alzheimer's disease for the benefit of our patients."
"There are currently 127 drugs in trials for Alzheimer's disease. Lecanemab and donanemab – which prompt the body to remove amyloid plaque in the brain – slow decline by about 30%."
Collection
[
|
...
]